E815
TEAS SECTION 8 & 15 RECEIVED
05/26/2026
Back to search
Official data from USPTO
CELL THERAPY NEXT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELL THERAPY NEXT
ST13
US500000088066392Class
16, 41, 42, 44
Filing
88066392
Registration
6064917
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/27/2026
Trademark type
Word
Nice classes
16, 41, 42, 44
Filing date
08/06/2018
Registration date
05/26/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2020
Last transaction
05/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-12-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
03
Owner location
Thorofare, NJ, US
Examiner
LIU, PHILIP HUAI-EN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Wyanoke Group, Inc.
Representatives
Kenneth R. DeRosa Lauletta Birnbaum, LLC
Technical classification
Nice Classes
Class 16Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Medical journals and magazines in the field of cellular therapy for the treatment of cancers featuring news and updated information on clinical research and trials and practical information for clinicians regarding treatment decisions
Class 41
Online electronic newsletters delivered by email in the field of cellular therapy for the treatment of cancers featuring news and updated information on clinical research and trials and practical information for clinicians regarding treatment decisions
Class 42
Providing a website featuring updates in the nature of news and updated information in the field of clinical research and clinical trials
Class 44
Providing a website featuring medical information in the field of cellular therapy for the treatment of cancers; providing a website intended for clinicians regarding treatment decisions related to cancer
Publications
History of USPTO decisions and trademark events.
26 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/26/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/20/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/02/2020
IUAF
USE AMENDMENT FILED
03/17/2020
EISU
TEAS STATEMENT OF USE RECEIVED
03/17/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/17/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/28/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/28/2018
GNRT
NON-FINAL ACTION E-MAILED
11/28/2018
CNRT
NON-FINAL ACTION WRITTEN
11/28/2018
DOCK
ASSIGNED TO EXAMINER
11/26/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2018
NWAP
NEW APPLICATION ENTERED
08/09/2018
Continuous trademark protection
Get notified about every new filing that threatens CELL THERAPY NEXT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.